ResMed | RMD - Cost Of Sales


ResMed reported $540.43M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Ansell USD 605.3M 351.2M Dec/2025
Avita Medical AUD 3.3M 166K Dec/2025
Cochlear AUD 319.2M 160.35M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Fisher & Paykel Healthcare NZD 435.5M 32.7M Jun/2026
Healius AUD 218.7M 110.8M Jun/2025
Integral Diagnostics AUD 11.53M 146K Jun/2024
Mayne Pharma AUD 43.74M 2.67M Jun/2024
Nanosonics AUD 24.22M 1.11M Dec/2025
Polynovo AUD 9.02M 3.51M Dec/2025
Ramsay Health Care AUD 3.05B 78.7M Dec/2025
ResMed USD 540.43M 4.15M Mar/2026
Sigma Healthcare AUD 1.55B 165.16M Dec/2024
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Telix Pharmaceuticals AUD 245.71M 24.35M Jun/2026